Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aclaris Therapeutics (ACRS) Revenue: 2017-2024

Historic Revenue for Aclaris Therapeutics (ACRS) over the last 8 years, with Dec 2024 value amounting to $18.7 million.

  • Aclaris Therapeutics' Revenue fell 24.09% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 41.87%. This contributed to the annual value of $18.7 million for FY2024, which is 40.09% down from last year.
  • As of FY2024, Aclaris Therapeutics' Revenue stood at $18.7 million, which was down 40.09% from $31.2 million recorded in FY2023.
  • Aclaris Therapeutics' Revenue's 5-year high stood at $31.2 million during FY2023, with a 5-year trough of $6.5 million in FY2020.
  • Over the past 3 years, Aclaris Therapeutics' median Revenue value was $29.8 million (recorded in 2022), while the average stood at $26.6 million.
  • Per our database at Business Quant, Aclaris Therapeutics' Revenue spiked by 340.05% in 2022 and then slumped by 40.09% in 2024.
  • Yearly analysis of 5 years shows Aclaris Therapeutics' Revenue stood at $6.5 million in 2020, then climbed by 4.30% to $6.8 million in 2021, then skyrocketed by 340.05% to $29.8 million in 2022, then grew by 5.03% to $31.2 million in 2023, then crashed by 40.09% to $18.7 million in 2024.